Discovery of dual-target natural inhibitors of meprins α and β metalloproteases for inflammation regulation: pharmacophore modelling, molecular docking, ADME prediction, and molecular dynamics studies

References

• M. Shankar-Hari, G.S. Phillips, M.L. Levy, C.W. Seymour, V.X. Liu, C.S. Deutschman, D.C. Angus, G.D. Rubenfeld, and M. Singer, Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (sepsis-3), JAMA 315 (2016), pp. 775–787. doi:10.1001/jama.2016.0289.
   PubMed Web of Science ®Google Scholar
• S. Rahn and C. Becker-Pauly, Meprin and ADAM proteases as triggers of systemic inflammation in sepsis, FEBS Lett. 596 (2021), pp. 534–556. doi:10.1002/1873-3468.14225.
   PubMed Web of Science ®Google Scholar
• K.V. Korneev, Mouse models of sepsis and septic shock, Mol. Biol. 53 (2019), pp. 704–717. doi:10.1134/S0026893319050108.
   Web of Science ®Google Scholar
• J.A. Stortz, S.L. Raymond, J.C. Mira, L.L. Moldawer, A.M. Mohr, and P.A. Efron, Murine models of sepsis and trauma: Can we bridge the gap? ILAR J. 58 (2017), pp. 90–105. doi:10.1093/ilar/ilx007.
   PubMed Web of Science ®Google Scholar
• C. Broder and C. Becker-Pauly, The metalloproteases meprin α and meprin β: Unique enzymes in inflammation, neurodegeneration, cancer and fibrosis, Biochem. J. 450 (2013), pp. 253–264. doi:10.1042/BJ20121751.
   PubMed Web of Science ®Google Scholar
• M. Drag and G.S. Salvesen, Emerging principles in protease-based drug discovery, Nat. Rev. Drug Discov. 9 (2010), pp. 690–701. doi:10.1038/nrd3053.
   PubMed Web of Science ®Google Scholar
• E.E. Sterchi, J.R. Green, and M.J. Lentze, Nonpancreatic hydrolysis of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (PABA peptide) in the rat small intestine, J. Pediatr. Gastroenterol. Nutr. 2 (1983), pp. 539–547. doi:10.1097/00005176-198302030-00024.
   PubMed Web of Science ®Google Scholar
• E.E. Sterchi, J.R. Green, and M.J. Lentze, Non-pancreatic hydrolysis of N-benzoyl-l-tyrosyl-p-aminobenzoic acid (PABA-peptide) in the human small intestine, Clin. Sci. 62 (1982), pp. 557–560. doi:10.1042/cs0620557.
   Web of Science ®Google Scholar
• R.J. Beynon, J.D. Shannon, and J.S. Bond, Purification and characterization of a metallo-endoproteinase from mouse kidney, Biochem. J. 199 (1981), pp. 591–598. doi:10.1042/bj1990591.
   PubMed Web of Science ®Google Scholar
• K. Barnes, J. Ingram, and A.J. Kenny, Proteins of the kidney microvillar membrane. Structural and immunochemical properties of rat endopeptidase-2 and its immunohistochemical localization in tissues of rat and mouse, Biochem. J. 264 (1989), pp. 335–346. doi:10.1042/bj2640335.
   PubMed Web of Science ®Google Scholar
• W. Jiang, P.M. Sadler, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, and J.S. Bond, Tissue-specific expression and chromosomal localization of the alpha subunit of mouse meprin A, J. Biol. Chem. 268 (1993), pp. 10380–10385. doi:10.1016/S0021-9258(18)82212-8.
   PubMed Web of Science ®Google Scholar
• C.M. Gorbea, P. Marchand, W. Jiang, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, and J.S. Bond, Cloning, expression, and chromosomal localization of the mouse meprin beta subunit, J. Biol. Chem. 268 (1993), pp. 21035–21043. doi:10.1016/S0021-9258(19)36890-5.
   PubMed Web of Science ®Google Scholar
• D. Hahn, R. Illisson, A. Metspalu, and E.E. Sterchi, Human N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase (human meprin): Genomic structure of the alpha and beta subunits, Biochem. J. 346 (2000), pp. 83–91. doi:10.1042/bj3460083.
   PubMed Web of Science ®Google Scholar
• J.S. Bond and R.J. Beynon, Mammalian metalloendopeptidases, Int. J. Biochem. 17 (1985), pp. 565–574. doi:10.1016/0020-711X(85)90287-3.
   PubMedGoogle Scholar
• J.S. Bond, R.J. Beynon, J.F. Reckelhoff, and C.S. David, Mep-1 gene controlling a kidney metalloendopeptidase is linked to the major histocompatibility complex in mice, Proc. Natl. Acad. Sci. USA 81 (1984), pp. 5542–5545. doi:10.1073/pnas.81.17.5542.
   PubMed Web of Science ®Google Scholar
• J.S. Bond and R.J. Beynon, The astacin family of metalloendopeptidases, Protein Sci. 4 (1995), pp. 1247–1261. doi:10.1002/pro.5560040701.
   PubMed Web of Science ®Google Scholar
• W. Stöcker and R. Zwilling, Astacin, Methods Enzymol. 248 (1995), pp. 305–325.
   PubMed Web of Science ®Google Scholar
• P. Saftig and K. Reiss, The “A disintegrin and metalloproteases” ADAM10 and ADAM17: Novel drug targets with therapeutic potential? Eur. J. Cell Biol. 90 (2011), pp. 527–535. doi:10.1016/j.ejcb.2010.11.005.
   PubMed Web of Science ®Google Scholar
• J. Scheller, A. Chalaris, C. Garbers, and S. Rose-John, ADAM17: A molecular switch to control inflammation and tissue regeneration, Trends Immunol. 32 (2011), pp. 380–387. doi:10.1016/j.it.2011.05.005.
   PubMed Web of Science ®Google Scholar
• K. Tan, C. Jäger, H. Körschgen, S. Geissler, D. Schlenzig, M. Buchholz, W. Stöcker, and D. Ramsbeck, Heteroaromatic inhibitors of the astacin proteinases meprin α, meprin β and ovastacin discovered by a scaffold-hopping approach, Chem. Med. Chem. 16 (2021), pp. 976–988. doi:10.1002/cmdc.202000822.
   Google Scholar
• L.P. Norman, G.L. Matters, J.M. Crisman, and J.S. Bond, Expression of Meprins in Health and Disease, in Current Topics in Developmental Biology, Academic Press, 2003, pp. 145–166.
   Google Scholar
• C. Almoguera, D. Shibata, K. Forrester, J. Martin, N. Arnheim, and M. Perucho, Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes, Cell 53 (1988), pp. 549–554. doi:10.1016/0092-8674(88)90571-5.
   PubMed Web of Science ®Google Scholar
• S. Banerjee, B. Oneda, L.M. Yap, D.P. Jewell, G.L. Matters, L.R. Fitzpatrick, F. Seibold, E.E. Sterchi, T. Ahmad, D. Lottaz, and J.S. Bond, MEP1A allele for meprin a metalloprotease is a susceptibility gene for inflammatory bowel disease, Mucosal. Immunol. 2 (2009), pp. 220–231. doi:10.1038/mi.2009.3.
   PubMed Web of Science ®Google Scholar
• G.P. Kaushal, R.S. Haun, C. Herzog, and S.V. Shah, Meprin a metalloproteinase and its role in acute kidney injury, Am. J. Physiol. Renal Physiol. 304 (2013), pp. F1150–8. doi:10.1152/ajprenal.00014.2013.
   PubMed Web of Science ®Google Scholar
• C. Becker-Pauly, M. Höwel, T. Walker, A. Vlad, K. Aufenvenne, V. Oji, D. Lottaz, E.E. Sterchi, M. Debela, V. Magdolen, H. Traupe, and W. Stöcker, The α and β subunits of the metalloprotease meprin are expressed in separate layers of human epidermis, revealing different functions in keratinocyte proliferation and differentiation, J. Invest. Dermatol. 127 (2007), pp. 1115–1125. doi:10.1038/sj.jid.5700675.
   PubMed Web of Science ®Google Scholar
• A. Kentsis, A. Shulman, S. Ahmed, E. Brennan, M.C. Monuteaux, Y.-H. Lee, S. Lipsett, J.A. Paulo, F. Dedeoglu, R. Fuhlbrigge, R. Bachur, G. Bradwin, M. Arditi, R.P. Sundel, J.W. Newburger, H. Steen, and S. Kim, Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease, EMBO Mol. Med. 5 (2013), pp. 210–220. doi:10.1002/emmm.201201494.
   PubMed Web of Science ®Google Scholar
• Z. Wang, C. Herzog, G.P. Kaushal, N. Gokden, and P.R. Mayeux, Actinonin, a meprin a inhibitor, protects the renal microcirculation during sepsis, Shock 35 (2011), pp. 141–147. doi:10.1097/SHK.0b013e3181ec39cc.
   PubMed Web of Science ®Google Scholar
• M.K. Holly, J.W. Dear, X. Hu, A.N. Schechter, M.T. Gladwin, S.M. Hewitt, P.S.T. Yuen, and R.A. Star, Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure, Kidney Int. 70 (2006), pp. 496–506. doi:10.1038/sj.ki.5001575.
   PubMed Web of Science ®Google Scholar
• C.C. Berthier, N. Lods, S.A. Joosten, C. van Kooten, D. Leppert, R.L.P. Lindberg, A. Kappeler, F. Raulf, E.E. Sterchi, D. Lottaz, and H.-P. Marti, Differential regulation of metzincins in experimental chronic renal allograft rejection: Potential markers and novel therapeutic targets, Kidney Int. 69 (2006), pp. 358–368. doi:10.1038/sj.ki.5000049.
   PubMed Web of Science ®Google Scholar
• C. Berthier and H.-P. Marti, Metzincins, including matrix metalloproteinases and meprin, in kidney transplantation, Swiss Med. Wkly. 137 (2007), pp. 109S–114S. doi:10.4414/smw.2006.11408.
   PubMedGoogle Scholar
• N.M. Raghavendra, D. Pingili, S. Kadasi, A. Mettu, and S.V.U.M. Prasad, Dual or multi-targeting inhibitors: The next generation anticancer agents, Eur. J. Med. Chem. 143 (2018), pp. 1277–1300. doi:10.1016/j.ejmech.2017.10.021.
   PubMed Web of Science ®Google Scholar
• M.T.A. Ocampo, W. Chaung, D.R. Marenstein, M.K. Chan, A. Altamirano, A.K. Basu, R.J. Boorstein, R.P. Cunningham, and G.W. Teebor, Targeted deletion of mNth1 reveals a novel DNA repair enzyme activity, Mol. Cell. Biol. 22 (2002), pp. 6111–6121. doi:10.1128/MCB.22.17.6111-6121.2002.
   PubMed Web of Science ®Google Scholar
• B. Papp, C. Pál, and L.D. Hurst, Metabolic network analysis of the causes and evolution of enzyme dispensability in yeast, Nature 429 (2004), pp. 661–664. doi:10.1038/nature02636.
   PubMed Web of Science ®Google Scholar
• P. Csermely, V. Ágoston, and S. Pongor, The efficiency of multi-target drugs: The network approach might help drug design, Trends Pharmacol. Sci. 26 (2005), pp. 178–182. doi:10.1016/j.tips.2005.02.007.
   PubMed Web of Science ®Google Scholar
• D. López, M.A. Fischbach, F. Chu, R. Losick, and R. Kolter, Structurally diverse natural products that cause potassium leakage trigger multicellularity in Bacillus subtilis, Proc. Natl. Acad. Sci. USA 106 (2009), pp. 280–285. doi:10.1073/pnas.0810940106.
   PubMed Web of Science ®Google Scholar
• L. Scotti, F.J. Bezerra Mendonca, F.F. Ribeiro, J.F. Tavares, M.S. da Silva, J.M. Barbosa Filho, and M.T. Scotti, Natural product inhibitors of topoisomerases: Review and docking study, Curr. Protein Pept. Sci. 19 (2017), pp. 275–291. doi:10.2174/1389203718666170111114442.
   Web of Science ®Google Scholar
• M.A.F. Nasution, E.P. Toepak, A.H. Alkaff, and U.S.F. Tambunan, Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus nucleocapsid (EBOV NP): A computational approach to discover new drug for combating Ebola, BMC Bioinform. 19 (2018), pp. 1–25. doi:10.1186/s12859-018-2387-8.
   PubMed Web of Science ®Google Scholar
• A.A. Alzain, R.M. Mukhtar, N. Abdelmoniem, F.A. Elbadwi, A. Hussien, W.A. Samman, S.R.M. Ibrahim, G.A. Mohamed, and A. Ashour, Computational insights into natural antischistosomal metabolites as smhdac8 inhibitors: Molecular docking, ADMET profiling, and molecular dynamics simulation, Metabolites 13 (2023), pp. 658. doi:10.3390/metabo13050658.
   PubMed Web of Science ®Google Scholar
• S.L. Dixon, A.M. Smondyrev, and S.N. Rao, PHASE: A novel approach to pharmacophore modeling and 3D database searching, Chem. Biol. Drug Des. 67 (2006), pp. 370–372. doi:10.1111/j.1747-0285.2006.00384.x.
   PubMed Web of Science ®Google Scholar
• A. Edris, M. Abdelrahman, W. Osman, A.E. Sherif, A. Ashour, E.A.E. Garelnabi, S.R.M. Ibrahim, R. Bafail, W.A. Samman, K.F. Ghazawi, G.A. Mohamed, and A.A. Alzain, Design of novel letrozole analogues targeting aromatase for breast cancer: Molecular docking, molecular dynamics, and theoretical studies on gold nanoparticles, Metabolites 13 (2023), pp. 583. doi:10.3390/metabo13050583.
   PubMed Web of Science ®Google Scholar
• H. Sun, Y. Li, S. Tian, L. Xu, and T. Hou, Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set, Phys. Chem. Chem. Phys. 16 (2014), pp. 16719–16729. doi:10.1039/C4CP01388C.
   PubMed Web of Science ®Google Scholar
• F.O. Obubeid, M.M. Eltigani, R.M. Mukhtar, R.A. Ibrahim, M.A. Alzain, F.A. Elbadawi, H. Ghaboosh, and A.A. Alzain, Dual targeting inhibitors for HIV-1 capsid and cyclophilin A: Molecular docking, molecular dynamics, and quantum mechanics, Mol. Simul. 48 (2022), pp. 1–14. doi:10.1080/08927022.2022.2097673.
   Web of Science ®Google Scholar
• V. Suryanarayanan and S.K. Singh, Assessment of dual inhibition property of newly discovered inhibitors against PCAF and GCN5 through in silico screening, molecular dynamics simulation and DFT approach, J. Recept. Signal Transduct. 35 (2015), pp. 370–380. doi:10.3109/10799893.2014.956756.
   PubMed Web of Science ®Google Scholar
• C. Coulouarn and B. Clément, Stellate cells and the development of liver cancer: Therapeutic potential of targeting the stroma, J. Hepatol. 60 (2014), pp. 1306–1309. doi:10.1016/j.jhep.2014.02.003.
   PubMed Web of Science ®Google Scholar
• J. Prox, P. Arnold, and C. Becker-Pauly, Meprin α and meprin β: Procollagen proteinases in health and disease, Matrix Biol. 44–46 (2015), pp. 7–13. doi:10.1016/j.matbio.2015.01.010.
   PubMed Web of Science ®Google Scholar
• P. Arnold, A. Otte, and C. Becker-Pauly, Meprin metalloproteases: Molecular regulation and function in inflammation and fibrosis, Biochim. Biophys. Acta Mol. Cell Res. 1864 (2017), pp. 2096–2104. doi:10.1016/j.bbamcr.2017.05.011.
   PubMed Web of Science ®Google Scholar
• C. Bayly-Jones, C.J. Lupton, C. Fritz, H. Venugopal, D. Ramsbeck, M. Wermann, C. Jäger, A. de Marco, S. Schilling, D. Schlenzig, and J.C. Whisstock, Helical ultrastructure of the metalloprotease meprin α in complex with a small molecule inhibitor, Nat. Commun. 131 (2022), pp. 1–14. doi:10.1038/s41467-022-33893-7.
   Google Scholar
• A. Schütte, A. Ermund, C. Becker-Pauly, M.E.V. Johansson, A.M. Rodriguez-Pineiro, F. Bäckhed, S. Müller, D. Lottaz, J.S. Bond, and G.C. Hansson, Microbial-induced meprin β cleavage in MUC2 mucin and a functional CFTR channel are required to release anchored small intestinal mucus, Proc. Natl. Acad. Sci. USA 111 (2014), pp. 12396–12401. doi:10.1073/pnas.1407597111.
   PubMed Web of Science ®Google Scholar
• C.T.N. Pham, Neutrophil serine proteases fine-tune the inflammatory response, Int. J. Biochem. Cell Biol. 40 (2008), pp. 1317–1333. doi:10.1016/j.biocel.2007.11.008.
   PubMed Web of Science ®Google Scholar
• V. Dive, D. Georgiadis, M. Matziari, A. Makaritis, F. Beau, P. Cuniasse, and A. Yiotakis, Phosphinic peptides as zinc metalloproteinase inhibitors, Cell. Mol. Life Sci. C 61 (2004), pp. 2010–2019. doi:10.1007/s00018-004-4050-y.
   PubMed Web of Science ®Google Scholar
• Y. Xu, L.T. Lai, J.L. Gabrilove, and D.A. Scheinberg, Antitumor activity of actinonin in vitro and in vivo, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 4 (1998), pp. 171–176.
   PubMed Web of Science ®Google Scholar
• C. Delclaux, C. Delacourt, M.P. D’Ortho, V. Boyer, C. Lafuma, and A. Harf, Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane, Am. J. Respir. Cell Mol. Biol. 14 (1996), pp. 288–295. doi:10.1165/ajrcmb.14.3.8845180.
   PubMed Web of Science ®Google Scholar
• F. Madoux, C. Tredup, T.P. Spicer, L. Scampavia, P.S. Chase, P.S. Hodder, G.B. Fields, C. Becker-Pauly, and D. Minond, Development of high throughput screening assays and pilot screen for inhibitors of metalloproteases meprin α and β, Biopolymers 102 (2014), pp. 396–406. doi:10.1002/bip.22527.
   PubMed Web of Science ®Google Scholar
• S. Banerjee, S.K. Baidya, B. Ghosh, S. Nandi, M. Mandal, T. Jha, and N. Adhikari, Quantitative structural assessments of potential meprin β inhibitors by non-linear QSAR approaches and validation by binding mode of interaction analysis, New J. Chem. 47 (2023), pp. 7051–7069. doi:10.1039/D2NJ04753E.
   Web of Science ®Google Scholar
• N. Adhikari, S.A. Amin, B. Ghosh, and T. Jha, Shedding light on designing potential meprin β inhibitors through ligand-based robust validated computational approaches: A proposal to chemists, J. Biomol. Struct. Dyn. 36 (2018), pp. 3003–3022. doi:10.1080/07391102.2017.1374210.
   PubMed Web of Science ®Google Scholar
• A. Chaudhuri, N. Hudait, and S. Sen Chakraborty, Pharmacophore modeling coupled with molecular dynamic simulation approach to identify new leads for meprin-β metalloprotease, Comput. Biol. Chem. 80 (2019), pp. 292–306. doi:10.1016/j.compbiolchem.2019.04.014.
   PubMed Web of Science ®Google Scholar
• Y. Dholey, A. Chaudhuri, and S. Sen Chakraborty, An integrated in silico approach to understand protein–protein interactions: Human meprin-β with fetuin-A, J. Biomol. Struct. Dyn. 38 (2020), pp. 2080–2092. doi:10.1080/07391102.2019.1626284.
   PubMed Web of Science ®Google Scholar
• A. Chaudhuri, S. Biswas, and S. Chakraborty, Exploring protein-protein intermolecular recognition between meprin-α and endogenous protease regulator cystatinC coupled with pharmacophore elucidation, J. Biomol. Struct. Dyn. 37 (2019), pp. 440–453. doi:10.1080/07391102.2018.1429311.
   PubMed Web of Science ®Google Scholar
• M. Linnert, C. Fritz, C. Jäger, D. Schlenzig, D. Ramsbeck, M. Kleinschmidt, M. Wermann, H.U. Demuth, C. Parthier, and S. Schilling, Structure and dynamics of meprin β in complex with a hydroxamate-based inhibitor, Int. J. Mol. Sci. 22 (2021), pp. 5651. doi:10.3390/ijms22115651.
   PubMed Web of Science ®Google Scholar